219 related articles for article (PubMed ID: 38498622)
1. Cost-effectiveness of point-of-care diagnostics for AMR: a systematic review.
Tolley A; Bansal A; Murerwa R; Howard Dicks J
J Antimicrob Chemother; 2024 Jun; 79(6):1248-1269. PubMed ID: 38498622
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT.
Francis NA; Gillespie D; White P; Bates J; Lowe R; Sewell B; Phillips R; Stanton H; Kirby N; Wootton M; Thomas-Jones E; Hood K; Llor C; Cals J; Melbye H; Naik G; Gal M; Fitzsimmons D; Alam MF; Riga E; Cochrane A; Butler CC
Health Technol Assess; 2020 Mar; 24(15):1-108. PubMed ID: 32202490
[TBL] [Abstract][Full Text] [Related]
3. Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-year-olds.
Nicholson KG; Abrams KR; Batham S; Medina MJ; Warren FC; Barer M; Bermingham A; Clark TW; Latimer N; Fraser M; Perera N; Rajakumar K; Zambon M
Health Technol Assess; 2014 May; 18(36):1-274, vii-viii. PubMed ID: 24875092
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial resistance point-of-care testing for gonorrhoea treatment regimens: cost-effectiveness and impact on ceftriaxone use of five hypothetical strategies compared with standard care in England sexual health clinics.
Harding-Esch EM; Huntington SE; Harvey MJ; Weston G; Broad CE; Adams EJ; Sadiq ST
Euro Surveill; 2020 Oct; 25(43):. PubMed ID: 33124553
[TBL] [Abstract][Full Text] [Related]
5. Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation.
Fraser H; Gallacher D; Achana F; Court R; Taylor-Phillips S; Nduka C; Stinton C; Willans R; Gill P; Mistry H
Health Technol Assess; 2020 Jun; 24(31):1-232. PubMed ID: 32605705
[TBL] [Abstract][Full Text] [Related]
6. Respiratory tract infections (RTIs) in primary care: narrative review of C reactive protein (CRP) point-of-care testing (POCT) and antibacterial use in patients who present with symptoms of RTI.
Cooke J; Llor C; Hopstaken R; Dryden M; Butler C
BMJ Open Respir Res; 2020 Sep; 7(1):. PubMed ID: 32895246
[TBL] [Abstract][Full Text] [Related]
7. In-vitro diagnostic point-of-care tests in paediatric ambulatory care: A systematic review and meta-analysis.
Van Hecke O; Raymond M; Lee JJ; Turner P; Goyder CR; Verbakel JY; Van den Bruel A; Hayward G
PLoS One; 2020; 15(7):e0235605. PubMed ID: 32628707
[TBL] [Abstract][Full Text] [Related]
8. Application of a simple point-of-care test to reduce UK healthcare costs and adverse events in outpatient acute respiratory infections.
Schneider JE; Boehme C; Borisch B; Dittrich S
J Med Econ; 2020 Jul; 23(7):673-682. PubMed ID: 32259465
[No Abstract] [Full Text] [Related]
9. Economic evaluation of antimicrobial resistance in curable sexually transmitted infections; a systematic review and a case study.
Ayinde O; Ross JDC; Jackson L
PLoS One; 2023; 18(10):e0292273. PubMed ID: 37856496
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains of
Turner KM; Christensen H; Adams EJ; McAdams D; Fifer H; McDonnell A; Woodford N
BMJ Open; 2017 Jun; 7(6):e015447. PubMed ID: 28615273
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of point-of-care C-Reactive Protein test compared to current clinical practice as an intervention to improve antibiotic prescription in malaria-negative patients in Afghanistan.
Dickinson S; Yi Chong H; Leslie T; Rowland M; Schultz Hansen K; Boyers D
PLoS One; 2021; 16(11):e0258299. PubMed ID: 34748558
[TBL] [Abstract][Full Text] [Related]
12. A systematic literature review of economic evaluation studies of interventions impacting antimicrobial resistance.
Painter C; Faradiba D; Chavarina KK; Sari EN; Teerawattananon Y; Aluzaite K; Ananthakrishnan A
Antimicrob Resist Infect Control; 2023 Jul; 12(1):69. PubMed ID: 37443104
[TBL] [Abstract][Full Text] [Related]
13. Modelling-based evaluation of the costs, benefits and cost-effectiveness of multipathogen point-of-care tests for sexually transmitted infections in symptomatic genitourinary medicine clinic attendees.
Huntington SE; Burns RM; Harding-Esch E; Harvey MJ; Hill-Tout R; Fuller SS; Adams EJ; Sadiq ST
BMJ Open; 2018 Sep; 8(9):e020394. PubMed ID: 30201794
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of point-of-care interventions to tackle inappropriate prescribing of antibiotics in high- and middle-income countries: a systematic review.
D'hulster E; De Burghgraeve T; Luyten J; Verbakel JY
J Antimicrob Chemother; 2023 Apr; 78(4):893-912. PubMed ID: 36825338
[TBL] [Abstract][Full Text] [Related]
15. Cost and cost-effectiveness of point-of-care testing and treatment for sexually transmitted and genital infections in pregnancy in low-income and middle-income countries: a systematic review protocol.
Saweri OP; Batura N; Adawiyah RA; Causer L; Pomat W; Vallely A; Wiseman V
BMJ Open; 2019 Nov; 9(11):e029945. PubMed ID: 31727649
[TBL] [Abstract][Full Text] [Related]
16. A cost-effectiveness and budget impact analysis of C-reactive protein point-of-care testing to guide antibiotic prescribing for acute respiratory tract infections in primary care settings in Ireland: a decision-analytic model.
Fawsitt CG; Lucey D; Harrington P; Jordan K; Marshall L; O'Brien KK; Teljeur C
Fam Pract; 2022 May; 39(3):389-397. PubMed ID: 34591966
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use.
Shrestha P; Cooper BS; Coast J; Oppong R; Do Thi Thuy N; Phodha T; Celhay O; Guerin PJ; Wertheim H; Lubell Y
Antimicrob Resist Infect Control; 2018; 7():98. PubMed ID: 30116525
[TBL] [Abstract][Full Text] [Related]
19. A protocol for a systematic literature review of economic evaluation studies of interventions to address antimicrobial resistance.
Ananthakrishnan A; Painter C; Teerawattananon Y
Syst Rev; 2021 Sep; 10(1):242. PubMed ID: 34488879
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
